SJ

Sharon Jackson

AP Aventis Pharmaceuticals: 5 patents #36 of 454Top 8%
DP Dupont Merck Pharmaceutical: 3 patents #46 of 228Top 25%
Overall (All Time): #657,338 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands James Hendrix, Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Joseph T. Strupczewski +10 more 2010-08-10
7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands James Hendrix, Joseph T. Strupczewski, Kenneth J. Bordeau, Matthias Urmann, Gregory M. Shutske +7 more 2009-06-23
7538233 Coumarins as iNOS inhibitors Thaddeus Nieduzak, Sam Rebello, Guyan Liang, Yulin Chiang, Jean Merrill 2009-05-26
7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands James Hendrix, Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Joseph T. Strupczewski +10 more 2009-04-21
7186724 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands James Hendrix, Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Jospeh T Strupczewski +10 more 2007-03-06
5849693 Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIb/IIIa Gregory J. Wells, John Wityak, Anju Parthasarathy, William F. DeGrado, Shaker A. Mousa 1998-12-15
5773411 Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIB/IIIA Gregory J. Wells, John Wityak, Anju Parthasarathy, William F. DeGrado, Shaker A. Mousa 1998-06-30
5635477 Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA William F. DeGrado, Shaker A. Mousa, Anju Parthasarathy, Michael Sworin, Maria Rafalski 1997-06-03